Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy

Caryn Hughes; Graeme Clemens; Matthew J. Baker

doi:10.1016/j.tibtech.2015.03.010

Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy

Caryn Hughes^*, Graeme Clemens, Matthew J. Baker

^*Corresponding author for this work

Pure And Applied Chemistry

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

98 Downloads (Pure)

Abstract

High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.

Original language	English
Pages (from-to)	429-430
Number of pages	2
Journal	Trends in Biotechnology
Volume	33
Issue number	8
Early online date	10 Apr 2015
DOIs	https://doi.org/10.1016/j.tibtech.2015.03.010
Publication status	Published - 17 Jul 2015

Keywords

cancer
infrared
spectroscopy
high throughput
preclinical screening
biomarker

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.tibtech.2015.03.010

Hughes-etal-TIB-2015-Preclinical-screening-of-anticancer-drugs-using-infraredAccepted author manuscript, 466 KBLicence: CC BY-NC-ND 4.0

Cite this

@article{89a272f6fe8840ce94e733c1759c911c,

title = "Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy",

abstract = "High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.",

keywords = "cancer, infrared, spectroscopy, high throughput, preclinical screening, biomarker",

author = "Caryn Hughes and Graeme Clemens and Baker, {Matthew J.}",

year = "2015",

month = jul,

day = "17",

doi = "10.1016/j.tibtech.2015.03.010",

language = "English",

volume = "33",

pages = "429--430",

journal = "Trends in Biotechnology",

issn = "0167-7799",

number = "8",

}

TY - JOUR

T1 - Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy

AU - Hughes, Caryn

AU - Clemens, Graeme

AU - Baker, Matthew J.

PY - 2015/7/17

Y1 - 2015/7/17

N2 - High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.

AB - High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.

KW - cancer

KW - infrared

KW - spectroscopy

KW - high throughput

KW - preclinical screening

KW - biomarker

UR - http://www.scopus.com/inward/record.url?scp=84926660775&partnerID=8YFLogxK

U2 - 10.1016/j.tibtech.2015.03.010

DO - 10.1016/j.tibtech.2015.03.010

M3 - Article

SN - 0167-7799

VL - 33

SP - 429

EP - 430

JO - Trends in Biotechnology

JF - Trends in Biotechnology

IS - 8

ER -

Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this